GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (LSE:FUM) » Definitions » Cyclically Adjusted PS Ratio

Futura Medical (LSE:FUM) Cyclically Adjusted PS Ratio : 37.35 (As of Jun. 02, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Futura Medical Cyclically Adjusted PS Ratio?

As of today (2024-06-02), Futura Medical's current share price is £0.3735. Futura Medical's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was £0.01. Futura Medical's Cyclically Adjusted PS Ratio for today is 37.35.

The historical rank and industry rank for Futura Medical's Cyclically Adjusted PS Ratio or its related term are showing as below:

LSE:FUM' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 29   Med: 38.3   Max: 64.83
Current: 64.83

During the past 13 years, Futura Medical's highest Cyclically Adjusted PS Ratio was 64.83. The lowest was 29.00. And the median was 38.30.

LSE:FUM's Cyclically Adjusted PS Ratio is ranked worse than
94.64% of 504 companies
in the Biotechnology industry
Industry Median: 5.425 vs LSE:FUM: 64.83

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Futura Medical's adjusted revenue per share data of for the fiscal year that ended in Dec23 was £0.011. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is £0.01 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Futura Medical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Futura Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical Cyclically Adjusted PS Ratio Chart

Futura Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 44.26

Futura Medical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 44.26

Competitive Comparison of Futura Medical's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Futura Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Futura Medical's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Futura Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Futura Medical's Cyclically Adjusted PS Ratio falls into.



Futura Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Futura Medical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.3735/0.01
=37.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Futura Medical's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Futura Medical's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.011/130.5000*130.5000
=0.011

Current CPI (Dec23) = 130.5000.

Futura Medical Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.000 99.900 0.000
201512 0.000 100.400 0.000
201612 0.002 102.200 0.003
201712 0.003 105.000 0.004
201812 0.000 107.100 0.000
201912 0.000 108.500 0.000
202012 0.000 109.400 0.000
202112 0.000 114.700 0.000
202212 0.000 125.300 0.000
202312 0.011 130.500 0.011

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Futura Medical  (LSE:FUM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Futura Medical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Futura Medical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Futura Medical (LSE:FUM) Business Description

Traded in Other Exchanges
Address
40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG
Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief.

Futura Medical (LSE:FUM) Headlines

No Headlines